Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C108123 |
4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine |
4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine results in decreased activity of RET protein | decreases activity | 16940797
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of RET mRNA | affects expression | 16483693
|
D000841 |
Anisomycin |
Anisomycin results in decreased expression of RET protein | decreases expression | 17555550
|
C006780 |
bisphenol A |
bisphenol A results in decreased expression of RET mRNA | decreases expression | 12075121
|
D019256 |
Cadmium Chloride |
[sodium arsenite co-treated with Cadmium Chloride co-treated with chromium oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of RET mRNA | affects cotreatment|decreases expression | 12634122
|
C055494 |
caffeic acid phenethyl ester |
[Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of RET mRNA | affects cotreatment|decreases expression | 20360939
|
D002166 |
Camptothecin |
Camptothecin results in decreased expression of RET protein | decreases expression | 17555550
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride affects the expression of RET mRNA | affects expression | 12734012
|
C023600 |
chromium oxide |
[sodium arsenite co-treated with Cadmium Chloride co-treated with chromium oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of RET mRNA | affects cotreatment|decreases expression | 12634122
|
C017133 |
chromous chloride |
[sodium arsenite co-treated with Cadmium Chloride co-treated with chromium oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of RET mRNA | affects cotreatment|decreases expression | 12634122
|
D003513 |
Cycloheximide |
Cycloheximide results in decreased expression of RET protein | decreases expression | 17555550
|
C017180 |
decamethrin |
decamethrin results in increased expression of RET mRNA | increases expression | 19017407
|
D002945 |
Cisplatin |
Cisplatin results in decreased expression of RET protein | decreases expression | 17555550
|
D004052 |
Diethylnitrosamine |
[Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of RET mRNA | affects cotreatment|decreases expression | 20360939
|
D002117 |
Calcitriol |
Calcitriol results in increased expression of RET mRNA | increases expression | 16002434
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in decreased expression of RET mRNA | decreases expression | 12075121
|
D019833 |
Genistein |
Genistein results in increased expression of RET mRNA | increases expression | 12075121
|
C097613 |
imatinib |
imatinib results in decreased phosphorylation of RET protein | decreases phosphorylation | 15709206
|
C008261 |
lead acetate |
[sodium arsenite co-treated with Cadmium Chloride co-treated with chromium oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of RET mRNA | affects cotreatment|decreases expression | 12634122
|
C533894 |
LG 100815 |
LG 100815 results in decreased expression of RET mRNA | decreases expression | 16951191
|
C025340 |
manganese chloride |
manganese chloride results in decreased expression of RET protein | decreases expression | 17555550
|
D008468 |
Meclizine |
Meclizine affects the expression of RET protein | affects expression | 12388792
|
D008535 |
Megestrol |
Megestrol affects the expression of RET protein | affects expression | 12388792
|
D008704 |
Methazolamide |
Methazolamide affects the expression of RET protein | affects expression | 12388792
|
D015632 |
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine |
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of RET protein | decreases expression | 17555550
|
C452423 |
N-(4-bromo-2-fluorophenyl)-6-methoxy-7-((1-methylpiperidin-4-yl)methoxy)quinazolin-4-amine |
N-(4-bromo-2-fluorophenyl)-6-methoxy-7-((1-methylpiperidin-4-yl)methoxy)quinazolin-4-amine results in decreased phosphorylation of RET protein | decreases phosphorylation | 17431108
|
C452423 |
N-(4-bromo-2-fluorophenyl)-6-methoxy-7-((1-methylpiperidin-4-yl)methoxy)quinazolin-4-amine |
N-(4-bromo-2-fluorophenyl)-6-methoxy-7-((1-methylpiperidin-4-yl)methoxy)quinazolin-4-amine results in decreased activity of RET protein | decreases activity | 17431108 16940797
|
C062198 |
octa-2,4,6-trienoic acid |
octa-2,4,6-trienoic acid results in decreased expression of RET mRNA | decreases expression | 16951191
|
D020849 |
Raloxifene |
[Raloxifene co-treated with ESR1 protein] results in increased expression of RET mRNA | affects cotreatment|increases expression | 19059307
|
D020849 |
Raloxifene |
[Raloxifene co-treated with ESR2 protein] results in decreased expression of RET mRNA | affects cotreatment|decreases expression | 19059307
|
D012402 |
Rotenone |
Rotenone results in decreased expression of RET mRNA | decreases expression | 17555550
|
D012402 |
Rotenone |
Rotenone results in decreased expression of RET protein | decreases expression | 17555550
|
C017947 |
sodium arsenite |
[sodium arsenite co-treated with Cadmium Chloride co-treated with chromium oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of RET mRNA | affects cotreatment|decreases expression | 12634122
|
D019311 |
Staurosporine |
Staurosporine results in decreased expression of RET protein | decreases expression | 17555550
|
D013467 |
Sulindac |
Sulindac affects the expression of RET protein | affects expression | 12388792
|
D013629 |
Tamoxifen |
[Tamoxifen co-treated with ESR1 protein] results in increased expression of RET mRNA | affects cotreatment|increases expression | 19059307
|
D013629 |
Tamoxifen |
[Tamoxifen co-treated with ESR2 protein] results in decreased expression of RET mRNA | affects cotreatment|decreases expression | 19059307
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of RET mRNA | increases expression | 17337447
|
D014212 |
Tretinoin |
RET protein results in increased susceptibility to Tretinoin | increases response to substance | 16849523
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of and results in increased phosphorylation of and results in increased activity of RET protein | increases activity|increases expression|increases phosphorylation | 16849523
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of RET mRNA | increases expression | 16012519 17431108
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of RET protein | increases expression | 17435603
|
D014212 |
Tretinoin |
Tretinoin results in increased phosphorylation of RET protein | increases phosphorylation | 17431108
|
D014212 |
Tretinoin |
[Tretinoin results in increased secretion of GDNF protein] which results in increased activity of RET protein | increases activity|increases secretion | 16849523
|
D014700 |
Verapamil |
Verapamil affects the expression of RET protein | affects expression | 12388792
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Sulindac |
11.77 | 14745880 |
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
11.77 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.49 | 15322242 14514962 11752688 |
MESH:D000015 |
Abnormalities, Multiple |
|
imatinib |
4.93 | 18322153 |
MESH:D000022 |
Abortion, Spontaneous |
|
imatinib |
5.84 | 18322153 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.19 | 18287403 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.57 | 17505938 |
MESH:D058186 |
Acute Kidney Injury |
|
Cisplatin |
7.97 | 12690470 17670903 15814532 |
MESH:D058186 |
Acute Kidney Injury |
|
Sulindac |
7.97 | 7897758 |
MESH:D000230 |
Adenocarcinoma |
|
Cisplatin |
9.38 | 17638652 11798837 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
9.38 | 14692618 |
MESH:D000230 |
Adenocarcinoma |
|
Genistein |
9.38 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Sulindac |
9.38 | 11910360 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
6.32 | 6695378 10737359 |
MESH:D000236 |
Adenoma |
|
Sulindac |
6.32 | 10223192 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
8.83 | 19061943 18056438 16434500 17620307 19052882 17162532 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
8.83 | 16835633 |
MESH:D011125 |
Adenomatous Polyposis Coli |
|
Sulindac |
4.28 | 16460482 11874996 19003578 15623613 12394442 11535846 17611924 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.32 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.53 | 17306315 16712894 |
MESH:D000419 |
Albuminuria |
|
Raloxifene |
4.25 | 17308373 17451421 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.33 | 15955085 |
MESH:D000544 |
Alzheimer Disease |
|
Raloxifene |
2.46 | 15800139 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.63 | 11748828 |
MESH:D000756 |
Anemia, Sideroblastic |
|
manganese chloride |
4.64 | 16910769 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.11 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
6.44 | 15885639 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
6.44 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.17 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.23 | 16456186 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.05 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
7.85 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
7.85 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.42 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.53 | 15746008 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Cisplatin |
4.51 | 14601052 |
MESH:D001859 |
Bone Neoplasms |
|
imatinib |
4.99 | 15867366 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
3.54 | 11985600 |
MESH:D001913 |
Bowen's Disease |
|
Sulindac |
4.98 | 11207687 |
MESH:D001930 |
Brain Injuries |
|
Raloxifene |
4.12 | 16580743 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
7.79 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
Calcitriol |
7.79 | 11237771 |
MESH:D001943 |
Breast Neoplasms |
|
Cisplatin |
7.79 | 19526202 18382427 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
7.79 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Genistein |
7.79 | 16541309 17200150 16873071 |
MESH:D001943 |
Breast Neoplasms |
|
imatinib |
7.79 | 17614352 |
MESH:D001943 |
Breast Neoplasms |
|
Raloxifene |
7.79 | 17049068 17595753 17893378 17440819 17952589 16837676 15758505 17242785 15572757 16912660 15775269 17261762 |
MESH:D001943 |
Breast Neoplasms |
|
Sulindac |
7.79 | 16642371 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
7.79 | 19200415 19103187 17893378 18351453 20005174 19115204 18997820 20544844 16873071 11161223 19487384 18855134 17049068 19142967 18425577 18629630 19244106 15565566 17440819 16273361 16818667 16202921 21152245 19155303 19288272 20135344 19289846 15668708 20859285 19059307 20390343 20065188 19410462 19189210 18821012 17242785 18815881 21138602 18984771 19084267 17261762 19221464 19011961 19066611 19189212 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
7.79 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
7.79 | 16873071 16443354 16166294 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.22 | 16813970 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
3.42 | 15673190 16097048 10355542 18705752 16124888 15700767 16192424 3786805 15721981 16227642 16011737 16050911 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.51 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.15 | 19066611 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
4.78 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
13.03 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cisplatin |
13.03 | 17982673 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
13.03 | 18210153 16328049 18691550 19208518 16681979 17055752 17428255 16288022 10737359 17173139 20007298 10672840 19335982 16502159 20101231 18978308 21159647 16935385 20432363 20514400 16807293 16540662 19822196 16569478 11831363 16698587 19394651 17138121 18665156 20727157 19701751 20214788 18971187 17978847 20084675 19171122 3581430 18506893 17162532 19539802 20935162 18788625 3084413 16830150 19519916 17761372 18785209 19919837 18494052 16878318 19107877 19383236 16779866 18393292 20512989 20524982 19052882 19418558 18056438 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Genistein |
13.03 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
13.03 | 16507464 17306315 15276417 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
13.03 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
13.03 | 1917145 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
4.62 | 17123778 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
Cisplatin |
2.90 | 12023789 16685392 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Calcitriol |
9.86 | 11237771 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Cisplatin |
9.86 | 17066447 6189445 18337622 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
9.86 | 18572023 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
9.86 | 16096774 16051514 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Raloxifene |
8.44 | 17572228 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
8.44 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Methazolamide |
6.84 | 17124262 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
6.84 | 16120746 18850075 18670907 |
MESH:D002318 |
Cardiovascular Diseases |
|
Genistein |
6.66 | 16332659 |
MESH:D002318 |
Cardiovascular Diseases |
|
Raloxifene |
6.66 | 15775269 |
MESH:D002386 |
Cataract |
|
Tretinoin |
2.88 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
5.94 | 2727394 7505956 17174075 21159647 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
5.94 | 20056578 19524636 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.22 | 16129372 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
8.30 | 19052882 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
8.30 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
2.60 | 11677210 17333356 15861022 17681005 17110522 16919318 16105132 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
4.78 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
5.23 | 15340226 15668235 16354765 12621046 8697196 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
5.23 | 9407595 |
MESH:D003072 |
Cognition Disorders |
|
Raloxifene |
4.26 | 15800139 |
MESH:D003092 |
Colitis |
|
Tretinoin |
3.35 | 17035595 |
MESH:D003110 |
Colonic Neoplasms |
|
Genistein |
3.85 | 17182828 |
MESH:D003110 |
Colonic Neoplasms |
|
Sulindac |
3.85 | 12902858 12458338 |
MESH:D015179 |
Colorectal Neoplasms |
marker/mechanism |
|
| 21278247 18507500 |
MESH:D015179 |
Colorectal Neoplasms |
|
Cisplatin |
2.87 | 15273666 |
MESH:D015179 |
Colorectal Neoplasms |
|
Sulindac |
2.87 | 18059344 10666051 11076880 11197048 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.75 | 14669216 17141729 |
MESH:C536209 |
Congenital central hypoventilation syndrome |
marker/mechanism |
|
| |
MESH:D019465 |
Craniofacial Abnormalities |
|
decamethrin |
6.88 | 19861644 |
MESH:D019465 |
Craniofacial Abnormalities |
|
imatinib |
6.88 | 18322153 |
MESH:D019465 |
Craniofacial Abnormalities |
|
lead acetate |
6.88 | 19769572 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
6.88 | 10048152 15322242 20055451 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
6.88 | 9211117 16925845 9224671 9664655 14991402 10589399 9125849 8800419 9142499 17551590 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.00 | 19031437 |
MESH:D003865 |
Depressive Disorder, Major |
|
Raloxifene |
3.85 | 17474826 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
6.51 | 20387270 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Genistein |
6.51 | 16647724 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
6.51 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Raloxifene |
8.01 | 15920148 17451421 17308373 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
8.01 | 19279558 |
MESH:D003930 |
Diabetic Retinopathy |
|
Sulindac |
4.83 | 12861449 17621415 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
5.50 | 17522070 21278145 11566570 16177239 3732212 19085960 7120509 7440962 3786805 15968718 4309450 6884620 6623471 10915739 19336974 2869522 15998439 7179309 16227642 9327722 10092053 15027814 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
5.50 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
5.50 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Cisplatin |
7.28 | 15033597 19839026 12649298 12231392 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
7.28 | 11462148 |
MESH:D004487 |
Edema |
|
imatinib |
13.92 | 19703484 |
MESH:D004487 |
Edema |
|
Raloxifene |
13.92 | 15860553 |
MESH:D004487 |
Edema |
|
Staurosporine |
13.92 | 8273558 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
13.92 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
10.69 | 15322242 18230668 16714409 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
10.69 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Calcitriol |
19.07 | 15138306 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
19.07 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Raloxifene |
19.07 | 15845917 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
19.07 | 19031437 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Genistein |
4.22 | 16402032 |
MESH:D016889 |
Endometrial Neoplasms |
|
Genistein |
11.08 | 11473722 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
11.08 | 16202921 20544844 19155303 17893378 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
11.08 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Sulindac |
8.14 | 15652904 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
8.14 | 10568697 9294722 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
4.74 | 16302075 |
MESH:D004938 |
Esophageal Neoplasms |
|
Cisplatin |
4.67 | 15173087 16481741 15464296 16785472 17638652 |
MESH:D004938 |
Esophageal Neoplasms |
|
Sulindac |
4.67 | 12235107 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
7.93 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
7.93 | 16938888 9664655 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
21.18 | 16045604 17595544 15959796 19224547 12631006 61145 12795759 16239168 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
21.18 | 21071580 20387270 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
21.18 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
Raloxifene |
21.18 | 17473493 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
21.18 | 14986274 19224547 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.01 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.10 | 11858732 |
MESH:D005317 |
Fetal Growth Retardation |
|
lead acetate |
5.03 | 19769572 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Sulindac |
11.73 | 14745880 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
11.73 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
imatinib |
17.55 | 17453242 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Sulindac |
17.55 | 19069698 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
17.55 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
12.68 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
12.68 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
12.68 | 17994277 |
MESH:D005764 |
Gastroesophageal Reflux |
|
Sulindac |
4.66 | 11910360 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.31 | 16452187 |
MESH:D005909 |
Glioblastoma |
|
Genistein |
6.41 | 16598420 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
6.41 | 17312396 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.22 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Cisplatin |
7.09 | 15464296 15102660 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
7.09 | 16096774 |
MESH:D034381 |
Hearing Loss |
|
Cisplatin |
3.99 | 19898482 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
4.78 | 16084493 |
MESH:D006319 |
Hearing Loss, Sensorineural |
|
Cisplatin |
4.12 | 15464296 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
5.87 | 10048152 11294989 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
5.87 | 14991402 9664655 |
MESH:D006331 |
Heart Diseases |
|
Raloxifene |
3.28 | 11110106 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.01 | 11000095 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
3.25 | 19110552 19900420 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.54 | 15340226 16120746 12621046 |
MESH:D006627 |
Hirschsprung Disease |
marker/mechanism |
|
| |
MESH:D006689 |
Hodgkin Disease |
|
Cisplatin |
6.54 | 16200630 16170182 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
6.54 | 12676792 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.67 | 16959395 15340226 8697196 16354765 18606429 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
2.93 | 16870215 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
4.16 | 16899240 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.21 | 16778211 |
MESH:D006973 |
Hypertension |
|
Raloxifene |
7.99 | 15787275 17577099 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
7.99 | 18850075 18670907 |
MESH:D006973 |
Hypertension |
|
Verapamil |
7.99 | 17700361 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
3.73 | 15338365 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.45 | 16945680 16569931 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.12 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
5.82 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
5.82 | 12646999 15346721 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
10.36 | 18785209 |
MESH:D007249 |
Inflammation |
|
Sulindac |
10.36 | 3291741 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
10.36 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
10.36 | 12878042 12200463 |
MESH:D007299 |
Insect Bites and Stings |
|
decamethrin |
5.42 | 15189238 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
3.05 | 16393666 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.41 | 17994277 |
MESH:D007414 |
Intestinal Neoplasms |
|
caffeic acid phenethyl ester |
9.20 | 10783313 |
MESH:D007414 |
Intestinal Neoplasms |
|
Sulindac |
9.20 | 10213222 12663524 12628509 12351151 12584176 10223192 |
MESH:D007417 |
Intestinal Polyps |
|
Sulindac |
4.65 | 12394442 11245490 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
8.84 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
8.84 | 15992940 17551590 |
MESH:D007673 |
Kidney Cortex Necrosis |
|
Cisplatin |
4.77 | 15464296 |
MESH:D007674 |
Kidney Diseases |
|
Cadmium Chloride |
12.79 | 16962696 |
MESH:D007674 |
Kidney Diseases |
|
caffeic acid phenethyl ester |
12.79 | 15369732 |
MESH:D007674 |
Kidney Diseases |
|
Cisplatin |
12.79 | 18289764 19839026 12649298 15190930 12231392 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
12.79 | 20008137 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
2.75 | 18625569 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Cisplatin |
4.42 | 11231351 |
MESH:D007889 |
Leiomyoma |
|
Raloxifene |
4.16 | 16973256 |
MESH:D007938 |
Leukemia |
|
Genistein |
5.78 | 18980019 17468513 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
5.78 | 17143497 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
imatinib |
4.50 | 15748426 15107311 17301526 19208803 |
MESH:D007951 |
Leukemia, Myeloid |
|
imatinib |
8.88 | 17236224 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
8.88 | 16482212 19285840 16932348 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
2.01 | 19850784 16294345 17596541 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
caffeic acid phenethyl ester |
7.11 | 16766008 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
7.11 | 16935935 9834237 16766008 17361223 19029980 17294898 17301526 17712046 16140955 17368321 16788101 17217047 19225113 17107899 17506722 19642359 19075265 16891316 12679006 16823087 15748426 19035177 16331271 17339181 17649720 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.05 | 9224671 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
2.89 | 17567588 15342952 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
5.92 | 16221502 16943688 21278145 16239168 11903743 17157831 11408273 17174718 17334410 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
5.92 | 18522880 20032147 18665156 18407596 19638242 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
Sulindac |
3.99 | 12468960 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
8.05 | 18395914 12666154 15996030 17823541 15370692 15057751 18472094 17944888 18006644 16116963 12898905 12667390 15730626 12445421 12546737 16097048 12649538 18705752 12632514 18429990 14620537 18420326 15818738 17565644 15673190 17976157 17481882 18317297 18187930 16015684 15925388 14716496 17557913 16033810 18472332 18418968 17714472 18156304 15123356 20821823 17766677 18481824 12586293 18166357 17761835 18205269 16027843 15650968 14748882 17525996 18339082 17900296 16136751 16011737 17922224 18395095 16638106 12609069 17698563 10355542 16192424 13678700 17805973 15893842 15338365 14724832 18412020 18263696 12741479 17640975 17631135 15959796 15362042 14716833 12389079 11481614 18054572 15052691 17869086 15876570 17708605 18279442 18376398 17721639 15931870 12632512 16248980 18210741 14512876 18277467 12445418 18251166 12958196 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Genistein |
8.05 | 17823541 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
imatinib |
8.05 | 16596278 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
8.05 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
8.05 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
8.05 | 18397230 16248980 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
6.04 | 15720792 16964402 15830285 17285989 16246199 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
6.04 | 17034775 |
MESH:D008107 |
Liver Diseases |
|
Sulindac |
6.04 | 16867024 14986274 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
3.80 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
3.37 | 16899240 14706259 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
12.65 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
12.65 | 19833225 19690152 20405173 19812893 19073162 18977376 19256749 20583210 19427195 2862719 20118626 19294768 10737359 19996281 18978307 18648771 18644402 21167192 19551842 19254457 15885732 12112319 19090486 2422723 20492335 19255062 18754104 15175105 21047994 20452335 20501860 21278145 19850985 20101389 9163691 19499222 20434301 19638242 19426721 21071580 16942905 20137499 19642983 12771043 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
12.65 | 15276417 16712894 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
12.65 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
12.65 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
8.45 | 12014681 15583823 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
8.45 | 17942915 19539802 18164116 18308698 17854601 18775883 19004024 16842330 2563599 18544905 3124819 18282651 17174075 19519916 19126423 19009564 18093689 16267830 21159647 18079962 18253720 9362446 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
8.45 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
2.93 | 19095001 |
MESH:D008175 |
Lung Neoplasms |
|
Cisplatin |
7.88 | 17225452 11798837 6189445 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
7.88 | 21163286 20970405 6695378 20512841 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
7.88 | 16712894 15276417 17306315 17077188 19931552 |
MESH:D008175 |
Lung Neoplasms |
|
Sulindac |
7.88 | 15713900 19359593 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
7.88 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
7.88 | 19555203 11884234 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
3.39 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Genistein |
5.32 | 12929590 14578162 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
5.32 | 14580682 19196723 11731420 19196722 16827153 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
4.17 | 19453300 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.63 | 17453147 |
MESH:D008545 |
Melanoma |
|
Cisplatin |
9.00 | 18176117 15577323 18505091 17761969 16809738 17023156 12883367 16248763 11135225 18332650 16432458 12393984 12374674 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
9.00 | 16487513 19082730 |
MESH:D008545 |
Melanoma |
|
Sulindac |
9.00 | 16642371 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
9.00 | 12393984 19393235 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
9.00 | 16752155 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Cisplatin |
10.28 | 15990972 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
10.28 | 15990972 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.06 | 16940565 |
MESH:D008654 |
Mesothelioma |
|
Cisplatin |
3.09 | 17638057 |
MESH:D018200 |
Mixed Tumor, Mullerian |
|
Raloxifene |
5.18 | 15863610 |
MESH:D018813 |
Multiple Endocrine Neoplasia Type 2a |
marker/mechanism |
|
| |
MESH:D018814 |
Multiple Endocrine Neoplasia Type 2b |
marker/mechanism |
|
| |
MESH:D009101 |
Multiple Myeloma |
|
Raloxifene |
3.18 | 16497877 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
2.87 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
Genistein |
2.70 | 17141266 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.73 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Genistein |
3.38 | 17141266 |
MESH:D009232 |
Myxoma |
|
Raloxifene |
5.18 | 16343187 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
8.76 | 3581430 9029167 |
MESH:D009362 |
Neoplasm Metastasis |
|
imatinib |
8.76 | 15867366 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
8.76 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.39 | 19410462 |
MESH:D009369 |
Neoplasms |
|
Cisplatin |
7.28 | 16773208 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
7.28 | 11559025 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
7.28 | 16946489 16594593 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.31 | 20056578 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
imatinib |
9.94 | 17614352 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
9.94 | 19200415 19196722 19189210 |
MESH:D009395 |
Nephritis, Interstitial |
|
Cisplatin |
4.12 | 15464296 |
MESH:D009410 |
Nerve Degeneration |
|
Rotenone |
3.60 | 18619942 15790535 17356569 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
20.58 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Genistein |
20.58 | 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
20.58 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
20.58 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
6.51 | 12854658 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
6.51 | 9142499 |
MESH:D009447 |
Neuroblastoma |
|
Cisplatin |
3.26 | 8761367 |
MESH:D019636 |
Neurodegenerative Diseases |
|
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine |
12.73 | 12349958 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
12.73 | 20387270 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Sulindac |
12.73 | 16850258 17266991 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Cisplatin |
4.33 | 8761367 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
4.74 | 20387270 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine |
4.99 | 16725203 |
MESH:D010014 |
Osteolysis |
|
imatinib |
5.37 | 15867366 |
MESH:D010024 |
Osteoporosis |
|
Genistein |
6.57 | 19401787 |
MESH:D010024 |
Osteoporosis |
|
Raloxifene |
6.57 | 17882678 19059307 15775268 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Genistein |
9.02 | 16169203 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Raloxifene |
9.02 | 17893378 15579764 15758505 17823083 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
4.62 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
Cisplatin |
10.29 | 6897625 17225452 15464296 19769630 |
MESH:D010051 |
Ovarian Neoplasms |
|
Genistein |
10.29 | 19005980 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
10.29 | 15276417 17306315 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
10.29 | 16936753 |
MESH:D010146 |
Pain |
|
Sulindac |
6.13 | 3291741 |
MESH:D010146 |
Pain |
|
Tretinoin |
6.13 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Cisplatin |
11.22 | 19003803 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
11.22 | 16540662 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Sulindac |
11.22 | 16820089 11504793 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
11.22 | 15976015 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.35 | 11578682 |
MESH:D010300 |
Parkinson Disease |
|
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine |
5.70 | 11181820 15451049 16140633 |
MESH:D010300 |
Parkinson Disease |
|
Rotenone |
5.70 | 19114014 16140633 11535288 18619942 15451049 19232380 18191903 16412576 11445065 |
MESH:D020734 |
Parkinsonian Disorders |
|
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine |
8.85 | 12349958 |
MESH:D020734 |
Parkinsonian Disorders |
|
Rotenone |
8.85 | 18197244 15795934 15574749 15927086 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.87 | 12520081 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Cisplatin |
3.96 | 15464296 |
MESH:D010673 |
Pheochromocytoma |
marker/mechanism |
|
| |
MESH:D010997 |
Pleural Neoplasms |
|
Cisplatin |
4.97 | 17638057 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.21 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
3.25 | 2563599 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
imatinib |
4.28 | 12476293 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
8.29 | 10548101 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
8.29 | 11118676 11399792 11896295 11222880 |
MESH:D011470 |
Prostatic Hyperplasia |
|
Calcitriol |
4.41 | 15572423 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
3.88 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
1.87 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Calcitriol |
1.87 | 16644109 18247401 16289102 15754350 12479363 |
MESH:D011471 |
Prostatic Neoplasms |
|
Genistein |
1.87 | 16925846 15256057 15378649 |
MESH:D011471 |
Prostatic Neoplasms |
|
Raloxifene |
1.87 | 15731164 16220300 16536755 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
1.87 | 16039940 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
1.87 | 15067354 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.27 | 16636307 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
2.95 | 15861022 16919318 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.42 | 16723453 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.42 | 10548101 |
MESH:D011693 |
Purpura |
|
Raloxifene |
5.18 | 15770314 |
OMIM:164761 |
REARRANGED DURING TRANSFECTION PROTOONCOGENE |
marker/mechanism |
|
| |
OMIM:191830 |
RENAL ADYSPLASIA |
marker/mechanism |
|
| |
MESH:D051437 |
Renal Insufficiency |
|
Cisplatin |
4.05 | 15464296 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.49 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
3.76 | 16283617 16116481 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Cisplatin |
4.08 | 14601052 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
8.38 | 19524636 18572023 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
8.38 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
8.38 | 16467112 |
MESH:D055752 |
Small Cell Lung Carcinoma |
|
Cisplatin |
4.97 | 15464296 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
10.31 | 16709447 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
10.31 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
3.67 | 19457130 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.51 | 12854658 |
MESH:D013274 |
Stomach Neoplasms |
|
Cisplatin |
4.46 | 17522103 15958060 18396642 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
4.46 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
imatinib |
4.46 | 15786421 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
4.46 | 17261132 |
MESH:D020521 |
Stroke |
|
Raloxifene |
3.53 | 16837676 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
3.62 | 16045194 16684133 |
MESH:D024801 |
Tauopathies |
|
Camptothecin |
5.26 | 16930453 |
MESH:D013736 |
Testicular Neoplasms |
|
Cisplatin |
4.29 | 15464296 17225452 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.28 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
2.85 | 15669648 |
OMIM:155240 |
THYROID CARCINOMA, FAMILIAL MEDULLARY |
marker/mechanism |
|
| |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.53 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
marker/mechanism |
|
| 16940797 |
MESH:D013964 |
Thyroid Neoplasms |
|
4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine |
19.61 | 16940797 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
19.61 | 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
imatinib |
19.61 | 16940797 |
MESH:D013964 |
Thyroid Neoplasms |
|
N-(4-bromo-2-fluorophenyl)-6-methoxy-7-((1-methylpiperidin-4-yl)methoxy)quinazolin-4-amine |
19.61 | 16940797 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
19.61 | 16026305 17045167 |
MESH:D013978 |
Tibial Fractures |
|
Raloxifene |
4.83 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
3.47 | 16051514 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.00 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cisplatin |
10.71 | 17225452 12973940 15464296 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Raloxifene |
10.71 | 17572228 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
10.71 | 16452187 17306315 16712894 11723127 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
10.71 | 8653321 17572228 16712894 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Cisplatin |
14.07 | 16803524 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
14.07 | 11813266 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
14.07 | 16129372 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
4.63 | 14652134 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
8.51 | 14692618 |
MESH:D014594 |
Uterine Neoplasms |
|
Sulindac |
8.51 | 18645019 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.24 | 16752155 |
MESH:D014625 |
Vaginal Neoplasms |
|
Cisplatin |
4.25 | 15577323 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.06 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.22 | 12125929 |
MESH:D054556 |
Venous Thromboembolism |
|
Raloxifene |
4.83 | 16837676 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.21 | 14671159 15869587 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.71 | 16761959 |
MESH:D014839 |
Vomiting |
|
Cisplatin |
4.34 | 11897121 |
MESH:D014846 |
Vulvar Neoplasms |
|
Raloxifene |
5.18 | 16343187 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.87 | 15886252 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.66 | 16287080 |